CFD and type 2 diabetes mellitus: In conclusion, the distinct metabolic profile of the adipokines adipsin and visfatin in patients with type 2 diabetes enhance the potential role of the adipose tissue in the modulation of energy balance and glucose homeostasis have a potential clinical relevance as biomarkers for insulin sensitivity.